• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法布里病中α-半乳糖苷酶A基因剪接位点突变的分析。

Analysis of splice-site mutations of the alpha-galactosidase A gene in Fabry disease.

作者信息

Lai L-W, Whitehair O, Wu M-J, O'Meara M, Lien Y-H H

机构信息

Department of Medicine, University of Arizona Health Sciences Center, Tucson, Arizona 85724, USA.

出版信息

Clin Genet. 2003 Jun;63(6):476-82. doi: 10.1034/j.1399-0004.2003.00077.x.

DOI:10.1034/j.1399-0004.2003.00077.x
PMID:12786754
Abstract

Fabry disease is an X-linked disease caused by a defective lysosomal enzyme, alpha-galactosidase A, and characterized by skin lesions and multiorgan involvement, including kidney, heart, and the central nervous system. Currently more than 200 genotypes have been identified, including several aberrant splicing. However, most of the mutation analyses were performed using genomic sequencing only, and therefore some of the splicing mutations were misclassified as missense mutations. In order to predict the splicing event caused by each mutation, we conducted a literature search for all published mutations located near the splice sites, including exonic point mutations, and performed a splice-site score (SSS) analysis. The literature search identified 13 donor-site mutations, including four exonic mutations (S65T, D183S, K213N, and M267I), located at the end of exons 1, 3, 4, and 5, respectively, six acceptor-site mutations, and one new exon creation. All mutated splice sites, except for the one associated with the new exon creation, had a lower SSS than their respective natural sites. Cryptic or newly created sites were identified with SSS from 0.09 to 1.0. The predictions, based on SSS analysis, are in agreement with all six mutations with known cDNA sequence from the literature, including five mutations with exon skipping and one mutation with creation of a new acceptor site. For the S65T genotype, we performed reverse transcription-polymerase chain reaction (RT-PCR) analysis using RNA isolated from the whole-blood sample. We verified that a weak cryptic site (SSS = 0.09) 14 nucleotides downstream was activated and resulted in an insertion of 14 bp and a frameshift stop at codon 106. This change is more consistent with the clinical presentation of the patient, the classical Fabry disease, than the amino acid substitution (S65T), which does not affect the enzyme function. In conclusion, the SSS analysis is very useful for predicting splicing events and genotype/phenotype correlation in Fabry disease. As different mechanisms may be involved in pre-mRNA splicing, it is important to obtain cDNA sequencing for molecular diagnosis.

摘要

法布里病是一种X连锁疾病,由溶酶体酶α-半乳糖苷酶A缺陷引起,其特征为皮肤病变和多器官受累,包括肾脏、心脏和中枢神经系统。目前已鉴定出200多种基因型,包括几种异常剪接。然而,大多数突变分析仅使用基因组测序进行,因此一些剪接突变被错误分类为错义突变。为了预测每个突变引起的剪接事件,我们对所有位于剪接位点附近的已发表突变进行了文献检索,包括外显子点突变,并进行了剪接位点评分(SSS)分析。文献检索确定了13个供体位点突变,包括4个外显子突变(S65T、D183S、K213N和M267I),分别位于外显子1、3、4和5的末端,6个受体位点突变,以及1个新外显子的产生。除了与新外显子产生相关的那个突变剪接位点外,所有突变的剪接位点的SSS均低于其各自的天然位点。通过SSS鉴定出隐匿或新产生的位点,其分值为0.09至1.0。基于SSS分析的预测与文献中所有六个具有已知cDNA序列的突变一致,包括五个外显子跳跃突变和一个新受体位点产生的突变。对于S65T基因型,我们使用从全血样本中分离的RNA进行了逆转录-聚合酶链反应(RT-PCR)分析。我们证实,下游14个核苷酸处一个弱隐匿位点(SSS = 0.09)被激活,导致插入14个碱基对,并在密码子106处发生移码终止。这种变化比不影响酶功能的氨基酸替代(S65T)更符合患者(典型法布里病)的临床表现。总之,SSS分析对于预测法布里病的剪接事件和基因型/表型相关性非常有用。由于前体mRNA剪接可能涉及不同机制,因此获得cDNA测序以进行分子诊断很重要。

相似文献

1
Analysis of splice-site mutations of the alpha-galactosidase A gene in Fabry disease.法布里病中α-半乳糖苷酶A基因剪接位点突变的分析。
Clin Genet. 2003 Jun;63(6):476-82. doi: 10.1034/j.1399-0004.2003.00077.x.
2
Novel acceptor splice site mutation in the invariant AG of intron 6 of alpha-galactosidase A gene, causing Fabry disease. Mutations in brief no. 146. Online.
Hum Mutat. 1998;11(6):483. doi: 10.1002/(SICI)1098-1004(1998)11:6<483::AID-HUMU17>3.0.CO;2-5.
3
Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes.法布里病:经典型和变异型表型患者α-半乳糖苷酶A基因的35种突变
Mol Med. 1997 Mar;3(3):174-82.
4
Two novel mutations in the alpha-galactosidase gene in Japanese classical hemizygotes with Fabry disease.
Jpn J Hum Genet. 1996 Sep;41(3):313-21. doi: 10.1007/BF01913174.
5
Identification of a novel point mutation (S65T) in alpha-galactosidase A gene in Chinese patients with Fabry disease. Mutations in brief no. 169. Online.中国法布里病患者α-半乳糖苷酶A基因新的点突变(S65T)的鉴定。简短突变报道第169号。在线发表。
Hum Mutat. 1998;11(4):328-30. doi: 10.1002/(SICI)1098-1004(1998)11:4<328::AID-HUMU11>3.0.CO;2-N.
6
Abnormal Pre-mRNA Splicing in Exonic Fabry Disease-Causing GLA Mutations.异常前 mRNA 剪接在外显子 Fabry 病致病 GLA 突变中。
Int J Mol Sci. 2022 Dec 3;23(23):15261. doi: 10.3390/ijms232315261.
7
Invariant exon skipping in the human alpha-galactosidase A pre-mRNA: Ag+1 to t substitution in a 5'-splice site causing Fabry disease.人类α-半乳糖苷酶A前体mRNA中的恒定外显子跳跃:5'-剪接位点处的Ag+1到t替换导致法布里病。
Genomics. 1992 Apr;12(4):643-50. doi: 10.1016/0888-7543(92)90288-4.
8
Identification of four novel mutations in five unrelated Korean families with Fabry disease.
Clin Genet. 2000 Sep;58(3):228-33. doi: 10.1034/j.1399-0004.2000.580311.x.
9
Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.对神经纤维瘤病1型(NF1)剪接缺陷进行的广泛计算机分析揭示了5'剪接位点破坏后剪接结果的决定因素。
Hum Mutat. 2007 Jun;28(6):599-612. doi: 10.1002/humu.20493.
10
Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.通过变性高效液相色谱法检测导致法布里病的α-半乳糖苷酶A突变
Hum Mutat. 2005 Mar;25(3):299-305. doi: 10.1002/humu.20144.

引用本文的文献

1
Mutations Suppress Autophagy and Stimulate Lysosome Generation in Fabry Disease.突变抑制法布里病中的自噬并刺激溶酶体生成。
Cells. 2024 Mar 1;13(5):437. doi: 10.3390/cells13050437.
2
Abnormal Pre-mRNA Splicing in Exonic Fabry Disease-Causing GLA Mutations.异常前 mRNA 剪接在外显子 Fabry 病致病 GLA 突变中。
Int J Mol Sci. 2022 Dec 3;23(23):15261. doi: 10.3390/ijms232315261.
3
Genetic architecture of common non-Alzheimer's disease dementias.常见非阿尔茨海默病痴呆症的遗传结构。
Neurobiol Dis. 2020 Aug;142:104946. doi: 10.1016/j.nbd.2020.104946. Epub 2020 May 19.
4
Multiple phenotypic domains of Fabry disease and their relevance for establishing genotype- phenotype correlations.法布里病的多个表型领域及其在建立基因型-表型相关性中的意义。
Appl Clin Genet. 2019 Mar 5;12:35-50. doi: 10.2147/TACG.S146022. eCollection 2019.
5
Modulation the alternative splicing of GLA (IVS4+919G>A) in Fabry disease.调节法布里病中GLA(IVS4+919G>A)的可变剪接。
PLoS One. 2017 Apr 21;12(4):e0175929. doi: 10.1371/journal.pone.0175929. eCollection 2017.
6
Increased glycolipid storage produced by the inheritance of a complex intronic haplotype in the α-galactosidase A (GLA) gene.α-半乳糖苷酶A(GLA)基因中复杂内含子单倍型的遗传导致糖脂储存增加。
BMC Genet. 2015 Sep 3;16:109. doi: 10.1186/s12863-015-0267-z.
7
A pharmacogenetic approach to identify mutant forms of α-galactosidase A that respond to a pharmacological chaperone for Fabry disease.采用药物遗传学方法鉴定对法布雷病的药理学伴侣有反应的α-半乳糖苷酶 A 的突变形式。
Hum Mutat. 2011 Aug;32(8):965-77. doi: 10.1002/humu.21530. Epub 2011 Jul 12.
8
Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group.迈向法布里病实验室诊断的共识——欧洲专家组的建议
J Inherit Metab Dis. 2011 Apr;34(2):509-14. doi: 10.1007/s10545-010-9261-9. Epub 2011 Jan 13.
9
IL-7 receptor deficient SCID with a unique intronic mutation and post-transplant autoimmunity due to chronic GVHD.具有独特内含子突变且因慢性移植物抗宿主病导致移植后自身免疫的白细胞介素-7受体缺陷型重症联合免疫缺陷病。
Clin Immunol. 2007 Nov;125(2):159-64. doi: 10.1016/j.clim.2007.06.007. Epub 2007 Sep 12.
10
Structure-function relationships in alpha-galactosidase A.α-半乳糖苷酶A中的结构-功能关系
Acta Paediatr. 2007 Apr;96(455):6-16. doi: 10.1111/j.1651-2227.2007.00198.x.